Mission BioCapital
Overview
Mission BioCapital is a venture capital firm founded in 2009, focused on making pivotal early-stage investments in life sciences companies. The firm invests in therapeutics, diagnostics, medical devices, and drug delivery. It supports its portfolio companies through a unique model that combines capital investment with shared lab space and access to strategic partners via partnerships with incubators like MBC BioLabs and LabCentral. The firm has offices in Cambridge, MA, and San Francisco, CA.
Portfolio Companies
48
Website
missionbiocapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tune Therapeutics | Dec 2021 | Series A | Co-investor |
| Dren Bio | Oct 2026 | Early Funding | Co-investor |
| Mediar Therapeutics | Mar 2023 | Series A | Co-investor |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
| March Biosciences | Oct 2024 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Johannes Fruehauf
General Partner, Co-Founder
Peter Parker
Managing General Partner
Steve Tregay
Managing General Partner
Ulrik B. Nielsen
General Partner
Michael D Taylor
Operating Partner
Robert Blazej
Partner
Zach Collins
Partner
Cassidy Blundell
Principal
Chaya Patel
Principal
Clay Rowland
Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mission BioCapital based?
Mission BioCapital is headquartered in Cambridge, Massachusetts, United States.
When was Mission BioCapital founded?
Founding year information for Mission BioCapital is not publicly available.
How many portfolio companies does Mission BioCapital have?
Mission BioCapital has 48 portfolio companies in Caplight's dataset.
What are some companies in Mission BioCapital's portfolio?
Portfolio companies visible on Caplight include Tune Therapeutics, Dren Bio, Mediar Therapeutics, Nocion Therapeutics, March Biosciences.
What was Mission BioCapital's most recent investment shown here?
Mission BioCapital's most recent investment in this portfolio sample was in Dren Bio in 2026.
What sectors does Mission BioCapital focus on?
Mission BioCapital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Mission BioCapital focus on?
Mission BioCapital typically invests at the Early stage.
What is Mission BioCapital's AUM?
Mission BioCapital's assets under management are estimated at over $259.5M.